STRS Ohio’s iTeos Therapeutics ITOS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-7,100
| Closed | -$70.8K | – | 2242 |
|
|
2025
Q2 | $70.8K | Buy |
7,100
+1,900
| +37% | +$15.3K | ﹤0.01% | 1957 |
|
|
2025
Q1 | $31K | Hold |
5,200
| – | – | ﹤0.01% | 1815 |
|
|
2024
Q4 | $39.9K | Hold |
5,200
| – | – | ﹤0.01% | 1752 |
|
|
2024
Q3 | $53.1K | Hold |
5,200
| – | – | ﹤0.01% | 1793 |
|
|
2024
Q2 | $77.2K | Hold |
5,200
| – | – | ﹤0.01% | 1737 |
|
|
2024
Q1 | $70K | Sell |
5,200
-5,600
| -52% | -$61K | ﹤0.01% | 1730 |
|
|
2023
Q4 | $118K | Sell |
10,800
-4,300
| -28% | -$42.6K | ﹤0.01% | 1664 |
|
|
2023
Q3 | $165K | Hold |
15,100
| – | – | ﹤0.01% | 1616 |
|
|
2023
Q2 | $199K | Sell |
15,100
-19,600
| -56% | -$279K | ﹤0.01% | 1588 |
|
|
2023
Q1 | $472K | Buy |
34,700
+5,700
| +20% | +$102K | ﹤0.01% | 1346 |
|
|
2022
Q4 | $566K | Sell |
29,000
-3,200
| -10% | -$62.5K | ﹤0.01% | 1259 |
|
|
2022
Q3 | $613K | Buy |
32,200
+1,300
| +4% | +$29.9K | ﹤0.01% | 1212 |
|
|
2022
Q2 | $636K | Buy |
30,900
+9,000
| +41% | +$214K | ﹤0.01% | 1217 |
|
|
2022
Q1 | $704K | Sell |
21,900
-800
| -4% | -$29.1K | ﹤0.01% | 1269 |
|
|
2021
Q4 | $1.06M | Buy |
22,700
+11,800
| +108% | +$393K | ﹤0.01% | 1086 |
|
|
2021
Q3 | $294K | Buy |
+10,900
| New | +$285K | ﹤0.01% | 1668 |
|
|
2021
Q2 | – | Sell |
-14,300
| Closed | -$488K | – | 2329 |
|
|
2021
Q1 | $488K | Buy |
14,300
+11,600
| +430% | +$419K | ﹤0.01% | 1581 |
|
|
2020
Q4 | $91K | Hold |
2,700
| – | – | ﹤0.01% | 1904 |
|
|
2020
Q3 | $66K | Buy |
+2,700
| New | +$72.6K | ﹤0.01% | 1921 |
|
Other funds holding ITOS
STRS Ohio's ITOS Position: Q3 2025 in Review
STRS Ohio sold out of iTeos Therapeutics (ITOS) in Q3 2025, closing a stake of 7,100 shares — an estimated $70.8K sold.
STRS Ohio first reported a position in ITOS in Q3 2020 and held it in 19 quarters. The position peaked at $1.06M in Q4 2021. 1 fund tracked by Wall St. Rank holds ITOS as of Q3 2025.
- STRS Ohio reported no remaining iTeos Therapeutics position as of Q3 2025 after selling out during the quarter.
- STRS Ohio sold 7,100 iTeos Therapeutics shares in Q3 2025, an estimated $70.8K.
- STRS Ohio first reported a position in iTeos Therapeutics in Q3 2020 and held it in 19 quarters.
- STRS Ohio's iTeos Therapeutics position peaked at $1.06M in Q4 2021.
- 1 fund tracked by Wall St. Rank held iTeos Therapeutics as of Q3 2025.
Based on STRS Ohio's 13F filing for Q3 2025, filed 30 Oct 2025.